Table 3.
Stratification of 128 respondents according to confidence and non-confidence in knowledge regarding cannabinoid molecules
|
Not confident |
Confident |
P value |
---|---|---|---|
n = 95 | N = 33 | ||
Is there a role for use of any of the following options for rheumatic conditions? n (%) |
|
|
|
Pharma only |
21 (22) |
10 (30) |
NS |
Medical cannabis |
22 (23) |
16 (48) |
.008 |
No role |
50 (53) |
7 (21) |
.0006 |
Did not answer |
2 (2) |
0 (0) |
|
Have you previously recommended a trial of the following? n (%) |
|
|
|
Pharma only |
11 (12) |
11 (33) |
.007 |
Medical cannabis |
7 (7) |
9 (27) |
.006 |
Never |
77 (81) |
13 (39) |
< .0001 |
Would you recommend a trial of the following? n (%) |
|
|
|
Pharma only |
15 (16) |
10 (30) |
NS |
Medical cannabis |
13 (14) |
12 (36) |
.009 |
None |
65 (68) |
11 (33) |
.0008 |
Did not answer |
2 (2) |
0 (0) |
|
Would you write a medical cannabis prescription for a patient failing conventional treatments? n (%) |
|
|
|
Yes |
22 (23) |
14 (42) |
.043 |
No |
70 (74) |
17 (52) |
.029 |
Did not answer |
3 (3) |
2 (6) |
|
Would you write a medical cannabis prescription based on patient request regardless of previous treatments? n (%) |
|
|
|
Yes |
2 (2) |
3 (9) |
NS |
No |
90 (95) |
28 (85) |
NS |
Did not answer |
3 (3) |
2 (6) |
|
Confidence level regarding writing a medical cannabis prescription (dose, frequency) n (%) |
|
|
|
Expressed confidence |
3 (3) |
9 (27) |
.0002 |
Not confident |
92 (97) |
23 (70) |
< .0001 |
Did not answer | 0 (0) | 1 (3) |